Published 11 days ago

Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug

Summary by Medscape

The factor D inhibitor danicopan has been approved for use in Europe for patients with paroxysmal nocturnal hemoglobinuria with residual hemolytic anemia on standard therapy. Medscape Medical News

0 Articles

All

Left

Center

Right

Medscape

Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug

The factor D inhibitor danicopan has been approved for use in Europe for patients with paroxysmal nocturnal hemoglobinuria with residual hemolytic anemia on standard therapy. Medscape Medical News

11 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.